Degradation Study and Impurity Profiling of Some Marketed Drugs - Behera, Chinmaya Chidananda;Dev, Asish
29,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
15 °P sammeln
  • Broschiertes Buch

Detection, quantification, and control of impurities in drug and drug products have become unambiguous necessities as per the new Regulatory guidelines, predominantly by the International Conference on Harmonization (ICH) recommends routine analysis of all impurities 0.1% level through suitable analytical methods. So, it was essential to determine the impurities present in Brinzolamide, Cilnidipine and Loteprednol to guarantee its purity, potency and safety in the pharmaceutical products.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Detection, quantification, and control of impurities in drug and drug products have become unambiguous necessities as per the new Regulatory guidelines, predominantly by the International Conference on Harmonization (ICH) recommends routine analysis of all impurities 0.1% level through suitable analytical methods. So, it was essential to determine the impurities present in Brinzolamide, Cilnidipine and Loteprednol to guarantee its purity, potency and safety in the pharmaceutical products.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
CHINMAYA CHIDANANDA BEHERA, travaillant comme professeur adjoint à l'École de pharmacie et des sciences de la vie, Centurion University of Technology and Management, Odisha, Inde depuis le 12 août 2016, et s'intéresse à la conception in-silico Synthèse/Isolation de médicaments d'origine synthétique/naturelle & Développement de méthodes analytiques de l'ingrédient pharmaceutique actif.